Transgene SA
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a therapeutic vaccine, which is in phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in phase I/IIa clinical trial for the treatment of various solid tumors, such as gastrointestinal adenocarcinoma comprising stomach, pancreas, and colon; and BT-001, an oncolytic virus, which is in phase I/II clinical trial for the treatment of solid tumors. The company also develops TG1050, a therapeutic vaccine for the treatment of chronic hepatitis B; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, PersonGen BioTherapeutics, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Sanofi, BioInvent, and Randox. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS. Show More...
-
Website https://www.transgene.fr
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.67 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR -1.21 -1.35 -1.33 -1.31 -1.23 -1.17 -0.44 -0.51 0.13 -0.23 -0.23 Dividends EUR Payout Ratio % * Shares Mil 28.0 33.0 33.0 33.0 40.0 40.0 58.0 64.0 62.0 83.0 83.0 Book Value Per Share * EUR 5.65 5.13 3.05 2.31 2.39 1.12 0.25 0.45 0.21 0.26 0.79 Free Cash Flow Per Share * EUR -0.9 -1.28 -1.63 -1.53 -1.45 -1.33 -1.04 -0.55 -0.48 -0.37 Return on Assets % -21.23 -20.91 -24.41 -29.94 -36.4 -38.35 -22.52 -28.84 7.67 -16.79 -16.79 Financial Leverage (Average) 1.22 1.37 1.61 2.22 1.96 3.8 2.64 3.59 2.96 1.76 1.76 Return on Equity % -27.14 -26.84 -35.85 -54.88 -75.6 -94.27 -69.01 -86.53 24.78 -36.73 -36.73 Return on Invested Capital % -27.14 -27.72 -27.22 -35.19 -42.39 -45.65 -26.7 -32.47 8.64 -19.76 -19.76 Interest Coverage Current Ratio 9.94 6.81 5.07 2.56 3.67 1.91 3.72 3.48 1.52 2.66 2.66 Quick Ratio 0.14 6.64 4.91 2.13 3.18 1.39 3.13 2.73 0.91 2.47 2.47 Debt/Equity 0.37 0.71 0.59 1.65 1.13 1.82 1.31 0.4 0.4